A Genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers

Molecular Cancer

Volumn 9, Issue , 2010, Pages 44-

  Dunwell, Thomas ^a   Hesson, Luke ^a   Rauch, Tibor A ^b   Wang, Lihui ^c   Clark, Richard E ^c   Dallol, Ashraf ^a   Gentle, Dean ^a   Catchpoole, Daniel ^d   Maher, Eamonn R ^a   Pfeifer, Gerd P ^b   Latif, Farida ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EBF2; TRANSCRIPTION FACTOR TFAP2A; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; ASSAY; AUTOPHAGY; CANCER GENETICS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA REPAIR; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE TARGETING; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; METHYLATED CPG ISLAND RECOVERY ASSAY; PROGNOSIS; PROMOTER REGION; SCHOOL CHILD;

BLAST CRISIS; CELL LINE, TUMOR; CHILD; CLONING, MOLECULAR; DNA METHYLATION; DNA, NEOPLASM; EPITHELIUM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, NEOPLASM; GENETIC TESTING; GENOME, HUMAN; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; NEOPLASMS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA; SULFITES;

EID: 77950416884     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-44     Document Type: Article

References (34)

1. Galm O, Herman JG, Baylin SB. The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev 2006, 20:1-13. 10.1016/j.blre.2005.01.006, 16426940.
2. Esteller M. Epigenetics in cancer. N Engl J Med 2008, 358:1148-1159. 10.1056/NEJMra072067, 18337604.
3. Hesson LB, Cooper WN, Latif F. The role of RASSF1A methylation in cancer. Dis Markers 2007, 23:73-87.
4. Hesson LB, Dunwell TL, Cooper WN, et al. The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias. Mol Cancer 2009, 8:42. 10.1186/1476-4598-8-42, 2711046, 19570220.
5. Dunwell TL, Hesson LB, Pavlova T, et al. Epigenetic analysis of childhood acute lymphoblastic leukemia. Epigenetics 2009, 4:185-193.
6. Rauch T, Li H, Wu X, Pfeifer GP. MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res 2006, 66:7939-7947. 10.1158/0008-5472.CAN-06-1888, 16912168.
7. Rauch T, Wang Z, Zhang X, et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci USA 2007, 104:5527-5532. 10.1073/pnas.0701059104, 1838508, 17369352.
8. Rauch TA, Zhong X, Wu X, et al. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci USA 2008, 105:252-257. 10.1073/pnas.0710735105, 2224196, 18162535.
9. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC. Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3. 10.1186/gb-2003-4-5-p3, 12734009.
10. Lee TI, Jenner RG, Boyer LA, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006, 125:301-313. 10.1016/j.cell.2006.02.043, 16630818.
11. Savona M, Talpaz M. Getting to the stem of chronic myeloid leukaemia. Nat Rev Cancer 2008, 8:341-350. 10.1038/nrc2368, 18385684.
12. Tommasi S, Karm DL, Wu X, Yen Y, Pfeifer GP. Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res 2009, 11:R14. 10.1186/bcr2233, 2687719, 19250546.
13. Schlesinger Y, Straussman R, Keshet I, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007, 39:232-236. 10.1038/ng1950, 17200670.
14. Bennett LB, Schnabel JL, Kelchen JM, et al. DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma. Genes Chromosomes Cancer 2009, 48:828-841. 10.1002/gcc.20687, 2738630, 19530241.
15. Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008, 456:66-72. 10.1038/nature07485, 2603574, 18987736.
16. Reid AG, Nacheva EP. A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion. Leukemia 2004, 18:178-180. 10.1038/sj.leu.2403162, 14523459.
17. Kuang SQ, Tong WG, Yang H, et al. Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia 2008, 22:1529-1538. 10.1038/leu.2008.130, 18528427.
18. Pike BL, Greiner TC, Wang X, et al. DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia 2008, 22:1035-1043. 10.1038/leu.2008.18, 2654231, 18288132.
19. Dalgin GS, Drever M, Williams T, King T, DeLisi C, Liou LS. Identification of novel epigenetic markers for clear cell renal cell carcinoma. J Urol 2008, 180:1126-1130. 10.1016/j.juro.2008.04.137, 18639284.
20. Wajapeyee N, Raut CG, Somasundaram K. Activator protein 2alpha status determines the chemosensitivity of cancer cells: implications in cancer chemotherapy. Cancer Res 2005, 65:8628-8634. 10.1158/0008-5472.CAN-05-1059, 16204029.
21. Aita VM, Liang XH, Murty VV, et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999, 59:59-65. 10.1006/geno.1999.5851, 10395800.
22. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676. 10.1038/45257, 10604474.
23. Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003, 112:1809-1820. 297002, 14638851.
24. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 2003, 100:15077-15082. 10.1073/pnas.2436255100, 299911, 14657337.
25. Liang C, Feng P, Ku B, Dotan I, Canaani D, Oh BH, Jung JU. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 2006, 8:688-699. 10.1038/ncb1426, 16799551.
26. Takahashi Y, Coppola D, Matsushita N, et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 2007, 9:1142-1151. 10.1038/ncb1634, 2254521, 17891140.
27. Cadwell K, Liu JY, Brown SL, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008, 456:259-263. 10.1038/nature07416, 2695978, 18849966.
28. Gozuacik D, Kimchi A. DAPk protein family and cancer. Autophagy 2006, 2:74-79.
29. Toyota M, Ho C, Ahuja N, et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999, 59:2307-2312.
30. Zou H, Harrington JJ, Shire AM, et al. Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev 2007, 16:2686-2696. 10.1158/1055-9965.EPI-07-0518, 18086775.
31. Kondo T, Nakazawa T, Ma D, et al. Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas. Lab Invest 2009, 89:791-799. 10.1038/labinvest.2009.50, 19506552.
32. Shikauchi Y, Saiura A, Kubo T, Niwa Y, Yamamoto J, Murase Y, Yoshikawa H. SALL3 interacts with DNMT3A and shows the ability to inhibit CpG island methylation in hepatocellular carcinoma. Mol Cell Biol 2009, 29:1944-1958. 10.1128/MCB.00840-08, 2655625, 19139273.
33. Terasawa K, Toyota M, Sagae S, et al. Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines. Br J Cancer 2006, 94:914-921. 10.1038/sj.bjc.6602984, 2361363, 16479257.
34. Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, Cervantes F, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. Journal of Clinical Oncology 2009, 27:6041-6051. 10.1200/JCO.2009.25.0779, 19884523.